nPOD partners with Organ Procurement Organizations (OPOs) and tissue banks to identify deceased organ donors who wish to donate to research and have been diagnosed with type 1 diabetes or are pre-clinical (identified by autoantibody testing).
Biological markers associated with type 1 diabetes have been identified and are used by physicians and researchers to determine the predisposition and/or disease progression of a donor.